Novartis Investigative Site

Mexico City, Mexico CP 14080

0 studies enrolling now · 3 studies all time

What they study most

Alzheimers Disease, Cytokine Storm (Covid-19), Lupus Nephritis

Studies at this site

• Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis — Stopped early
• Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm — Completed
• A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease — Stopped early